Brief: Akzo Nobel Q1 Adjusted EBITDA Of EUR 345 Mln Beats Company-Compiled Consensus

Akzo Nobel NV

22/04/2026 06:21

April 22 (Reuters) - Akzo Nobel NV AKZO.AS:

Q1 ADJUSTED EBITDA EUR 345 MILLION VERSUS EUR 323 MILLION IN COMPANY-COMPILED CONSENSUS

Q1 ADJUSTED EBITDA MARGIN EXPANSION TO 14.5%

Q1 REVENUE EUR 2.39 BILLION VERSUS EUR 2.39 BILLION IN COMPANY-COMPILED CONSENSUS

Q1 OPERATING INCOME EUR 177 MILLION

ADJUSTED EBITDA FOR 2026 EXPECTED AT OR ABOVE €1.47 BILLION, BASED ON YEAR-END 2025 EXCHANGE RATES AND ADJUSTED FOR INDIA DIVESTMENT

FOR MID-TERM, CO AIMS TO EXPAND PROFITABILITY TO DELIVER ADJUSTED EBITDA MARGIN OF ABOVE 16% AND RETURN ON INVESTMENT BETWEEN 16% AND 19%

EXPECTS LEVERAGE TO BE AROUND 2 TIMES NET DEBT/ADJUSTED EBITDA BY THE END OF 2026

IN THE MID-TERM, AKZONOBEL AIMS TO MAINTAIN LEVERAGE AROUND 2 TIMES, WHILE REMAINING COMMITTED TO AN INVESTMENT GRADE CREDIT RATING

CLOSING OF THE AXALTA MERGER, WHICH IS SUBJECT TO SHAREHOLDER AND REGULATORY APPROVALS, IS EXPECTED IN LATE 2026 OR EARLY 2027

Q2 ADJ. EBITDA EXPECTED AROUND €400M

Source text: ID:nNDL688Y2V

Further company coverage: AKZO.AS

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))